๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Xining
Clinical trial register · China

Clinical Trials in Xining, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Xining 6 Jinan 1 Beijing 1
Narrow the registerReset
Recruitment status
Phase
Site location
Xining6 Jinan1 Beijing1
All 3 locations
Target enrolment
to

Trials with a site in Xining

6 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Hydromorphone With Electroacupuncture and Ear Acupoint Pressing for Refractory Cancer Pain
NCT07489625Refractory Cancer Pain, Cancer Pain
Qinghai Red Cross Hospital
Phase EARLY_PHASE1
30
Xining
2026-08-05
Recruiting
Study on the Efficacy and Safety of Mecobalamin in Preventing Taxane-related Peripheral Neuropathy
NCT07423390Peripheral Neuropathy Due to Chemotherapy, Peripheral Neuropathy, Chemotherapy-induced
Qinghai Red Cross Hospital
Phase 3
326
Xining, Jinan, Beijing
2026-02-24
Not yet open
Electroacupuncture for Preventing Adverse Events of Cancer Immunotherapy
NCT06891521Cancer, Adverse Events
Qinghai Red Cross Hospital
Phase 2
123
Xining
2025-03-20
Recruiting
Efficacy of Auricular Pressure Beans with Electroacupuncture and Estazolam Treating Insomnia Caused by Cancer
NCT06859190Cancer, Insomnia
Qinghai Red Cross Hospital
Phase 3
60
Xining
2025-03-01
Recruiting
Metabolomic and Lipidomic Analysis Predicts Immunotherapy-related Adverse Events in Gastric Cancer Patients
NCT06915389Gastric Cancer, Immunotherapy, Adverse Event, Metabonomics
Qinghai Red Cross Hospital
Observational
100
Xining
2025-02-22
Recruiting
Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer
NCT06338683Advanced Cancer, Olanzapine, Progression Free Survival
Qinghai Red Cross Hospital
Phase 3
230
Xining
2024-03-20
Rows per page Showing 1–6 of 6
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/city/xining

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 6 of those studies with a site in Xining that also match the filters currently applied.

How many clinical trials are recruiting in Xining?

5 of the 6 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 1 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Xining), 6 studies
PhaseStudiesRecruitingShare
Phase 33350%
Observational1116.7%
Phase 21016.7%
Phase EARLY_PHASE11116.7%

Most active sponsors

Lead sponsors with the most studies (Xining)
Lead sponsorStudiesRecruiting
Qinghai Red Cross Hospital65
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.